Download PDF
Thromb Haemost 1990; 63(03): 345-348
DOI: 10.1055/s-0038-1645044
Original Article
Schattauer GmbH Stuttgart

Effects of Moderate Alcohol Consumption on Platelet Function, Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor

J Veenastra
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
,
C Kluft
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
,
Th Ockhuizen
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
,
H v d Pol
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
,
M Wedel
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
,
G Schaafsma
The TNO-CIVO Toxicology and Nutrition Institute, Zeist, The Netherlands and the TNO-Gaubius Institute, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 17 March 1989

Accepted after revision 19 January 1990

Publication Date:
30 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Short-term effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) were studied in two age groups of volunteers (20–30 and 45–55 years), each consisting of eight healthy males. The alcohol (30 g in red port and wine) was consumed during a standard dinner. Two blood samples were drawn: one in the postprandial phase, and one the next morning after fasting overnight. Alcohol consumption tended to increase platelet aggregation and production of hydroxy fatty acids, reduced plasma t-PA activity and increased PAI activity in the postprandial phase. After the overnight fast the effects on t-PA and PAI had disappeared whereas at that time alcohol consumption tended to decrease platelet function. The effects of alcohol on t-PA and PAI activity appeared mainly in the older age group, whereas the t-PA activity in this group was already much lower, irrespective of alcohol consumption.

 

  • References

  • 1 Marmot MG, Rose G, Shipley MJ. Alcohol and mortality: A U-shaped curve. Lancet 1981; i: 580-3
    PubMedGoogle Scholar
  • 2 Turner TB, Bennett LV, Hernandez H. The beneficial side of moderate alcohol use. Johns Hopkins Med J 1981; 148: 53-63
    PubMedGoogle Scholar
  • 3 Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol 1984; 13: 160-6
    CrossrefPubMedGoogle Scholar
  • 4 Moore DR. Pearson T Moderate alcohol consumption and coronary artery disease: a review. Medicine 1986; 65: 242-67
    CrossrefPubMedGoogle Scholar
  • 5 Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319: 267-73
    CrossrefPubMedGoogle Scholar
  • 6 Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men. Explaining the U-shaped curve. Lancet 1988; ii: 1267-73
    PubMedGoogle Scholar
  • 7 Letters to the editor. Alcohol and the U-shaped curve Lancet: 1989. i 105
    Google Scholar
  • 8 Letters to the editor. Alcohol and the U-shaped curve Lancet: 1989. i 224-5
    Google Scholar
  • 9 Shaper AG, Wannamethee G, Walker M. Alcohol and the U-shaped curve. Lancet 1989; i: 336
    PubMedGoogle Scholar
  • 10 Fenn CG, Littleton JM. Interactions between ethanol and dietary fat in determining human platelet function. Thromb Haemostas 1984; 51: 50-3
    PubMedGoogle Scholar
  • 11 Galli C, Colli S, Gianfranceschi G. Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma free fatty acids in normal subjects. Drug-Nutrient Interactions 1984; 3: 61-7
    PubMedGoogle Scholar
  • 12 Dunn EL, Cohen RG, Moore EfE, Hamstra RD. Acute alcohol ingestion and platelet function. Arch Surg 1981; 116: 1082-3
    CrossrefPubMedGoogle Scholar
  • 13 Mikhailidis DP, Jeremy JY, Barradas MA, Green N, Dandona P. Effect of ethanol on vascular prostacyclin synthesis, platelet aggregation and platelet thromboxane release. Br Med J 1983; 287: 1495-8
    CrossrefPubMedGoogle Scholar
  • 14 Hillbom M, Kangasaho M, Lowbeer C, Kaste M, Muuronen A, Numminen H. Effects of ethanol on platelet function. Alcohol 1985; 2: 429-32
    CrossrefPubMedGoogle Scholar
  • 15 DeWood MA, Spores J, Notske R. Prevelance of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902
    CrossrefPubMedGoogle Scholar
  • 16 Gram J, Jespersen J. A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterizes a risk group among survivors of acute myocardial infarction. Thromb Haemostas 1987; 57: 137-9
    PubMedGoogle Scholar
  • 17 Franzen J, Nilsson B, Johansson BW, Nilsson IM. Fibrinolytic activity in men with acute myocardial infarction before 60 years of age. Acta Med Scand 1983; 214: 339-44
    PubMedGoogle Scholar
  • 18 Hamsten A, WimanE B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-63
    CrossrefPubMedGoogle Scholar
  • 19 Hamsten A, Blomback M, Wiman B, Svensson J, Szamosi A, de FaireE U, Mettinger L. Haemostatic function in myocardial infarction. Br Heart J 1986; 55: 58-66
    CrossrefPubMedGoogle Scholar
  • 20 Nilsson TK, Johnson O. The extrinsic fibrinolytic system in survivors of myocardial infarction. Thromb Res 1987; 48: 621-30
    CrossrefPubMedGoogle Scholar
  • 21 Pikaar NA, Wedel M, van der Beek EJ, Dokkum Wv, Kempen MH J, Kluft C, Ockhuizen Th, Hermus JR J. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987; 36: 538-43
    CrossrefPubMedGoogle Scholar
  • 22 Veenstra J, Kluft C, Pikaar NA, Pol dH v, Schaafsma G, Ockhuizen Th. The effects of four days of moderate wine and coffee consumption on fibrinolysis and platelet aggregation. Submitted
    PubMedGoogle Scholar
  • 23 Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholinesterase as label: an alternative to radioimmunoassay. Anal Chem 1985; 57: 1170-3
    CrossrefPubMedGoogle Scholar
  • 24 Pradelles P, Grassi J, Maclouf J. Dosage enzymoimmunologique des métabolites de 1’acide arachidomque utilisant 1’acétylcholinesterase d’Electrophorus electricus. Ann Biol Chn 1985; 43: 475-84
    PubMedGoogle Scholar
  • 25 Veenstra J, Pol dH v, Torre dH v, Schaafsma G, Ockhuizen Th. Rapid and simple methods for the investigation of lipoxygenase pathways in human granulocytes. J Chrom 1988; 431: 413-7
    CrossrefPubMedGoogle Scholar
  • 26 Kluft C, Brakman P. Veldhuyzen-Stolk. Screeding of fibrinolytic activity in plasma euglubulin fractions on the fibrin plate. In: Progress in Chemical Fibrinolysis and Thrombolysis 2 Davidson JF, Samama MM, Desnoyers PC. (eds). Raven Press; New York: 1976: 57-65
  • 27 Verheijen JH, Mullaart E, Chang GG T, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma. Thromb Haemostas 1982; 48: 266-9
    PubMedGoogle Scholar
  • 28 Gaffney PJ, Curtis AD. A collaborative study of a proposed International standard for tissue plasminogen activator in human plasma. Thromb Haemostas 1985; 53: 134-6
    PubMedGoogle Scholar
  • 29 Verheijen JH, Chang GG T, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-5
    PubMedGoogle Scholar
  • 30 Rand ML, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effects of ethanol on pathways of platelet aggregation in vitro. Thromb Haemostas 1988; 59: 383-7
    PubMedGoogle Scholar
  • 31 Fenn CG, Littleton JM. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition. Thromb Haemostas 1982; 48: 49-53
    PubMedGoogle Scholar
  • 32 Lagarde M. Roles of cyclooxygenase and lipoxygenase metabolites in platelets. In: Platelets in Biology and Pathology III. MacIntyre Gordon. (eds). Elsevier Science Publishers B.V.; Amsterdam: 1987: 269-88
  • 33 Fearnly GR, Ferguson J, Chakrabarti R, Vincent CT. Effect of beer on blood fibrinolytic activity. Lancet 1960; i: 184-5
    PubMedGoogle Scholar
  • 34 Chakrabarti R. Overview of fibrinolysis. Scott Med J 1981; 51-6
    PubMedGoogle Scholar
  • 35 Rosing DR, Redwood DR, Brakman P, Astrup T, Epstein SE. Impairment of the diurnal fibrinolytic response in man: effect of aging, type IV hyperlipoproteinemia and coronary artery disease. Arc Res 1973; 32: 752-8
    PubMedGoogle Scholar
  • 36 Stegnar M, Keber D, Pentek M, Vene N, Kluft C. Age and sex differences in resting and postocclusion values of tissue plasminogen activator in a healthy population. Fibrinolysis 1988; 2 (Suppl. 02) 121-2
    PubMedGoogle Scholar